[ad_1]
[Berlín / Ginebra / Zúrich 15 de Reuters]- The governments of Germany, France and Italy announced on the 15th that they will suspend vaccination with the new coronavirus vaccine manufactured by AstraZeneca. Following reports of suspected adverse reactions, such as blood clots after vaccination, this could further affect the long-delayed European vaccination program.
In addition, Spanish radio Cadena SER has reported that vaccination will be suspended for at least 15 days in Spain, according to anonymous officials.
Denmark and Norway suspended vaccination last week for the AstraZeneca vaccine. Iceland, Bulgaria, Ireland and the Netherlands were also suspended.
Swaminasan, chief scientist at the World Health Organization (WHO), told an online press conference that so far no link between the new corona vaccine and thrombosis has been confirmed: “I don’t want you to panic.”
In Europe, Germany announced last week that it was facing a third wave of outbreaks. Italy has tightened its control measures in response to the re-spread of the infection, and the hospital’s response capacity is poor in Paris, the capital of France.
In these circumstances, the suspension of vaccination with AstraZeneca in major European countries such as Germany, France and Italy may raise concerns about the already delayed vaccination situation in Europe.
German Health Minister Sparn said the risk of blood clots is low, but the risk cannot be ruled out. The government said it had decided to suspend vaccination, following the advice of the Paul Erich Institute (PEI).
French President Emmanuel Macron has announced that he will stop vaccination until the European Medicines Agency (EMA) examines the AstraZeneca vaccine on the 16th. Italy has also called it a “preventive and temporary measure” until the authorities make a decision. .
Responses have been divided on AstraZeneca vaccines and the UK has stated that it has no concerns. Poland said the benefits outweigh the risks. Outside of Europe, Thailand announced that it would suspend vaccination on the 12th, but announced that it would resume vaccination on that day.
According to the EMA, around 5 million people in Europe have been vaccinated with the AstraZeneca vaccine, but as of March 10, 30 cases of thrombosis have been reported.
* Information has been added.
